Skip to main content
. 2020;12(2):34–41. doi: 10.17691/stm2020.12.2.04

Table 3.

Median survival rates in the newly formed groups of patients who received standard comprehensive treatment

Groups Median overall survival (months) Median survival since the last operation (months)
Group 1 with autologous lysate (n=12) 16 12
Group 2 with pooled lysate (n=7) 15 10
Group 3 without immunotherapy (n=10) 14.5 12